
Joseph H. Murray
Examiner (ID: 1129)
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1613, 1626 |
| Total Applications | 346 |
| Issued Applications | 321 |
| Pending Applications | 11 |
| Abandoned Applications | 14 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6481463
[patent_doc_number] => 20100092613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'CLONING AND EXPRESSION OF A NOVEL PHYTASE'
[patent_app_type] => utility
[patent_app_number] => 12/298948
[patent_app_country] => US
[patent_app_date] => 2006-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8687
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298948 | Cloning and expression of a novel phytase | Apr 29, 2006 | Issued |
Array
(
[id] => 6481463
[patent_doc_number] => 20100092613
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'CLONING AND EXPRESSION OF A NOVEL PHYTASE'
[patent_app_type] => utility
[patent_app_number] => 12/298948
[patent_app_country] => US
[patent_app_date] => 2006-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8687
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20100092613.pdf
[firstpage_image] =>[orig_patent_app_number] => 12298948
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/298948 | Cloning and expression of a novel phytase | Apr 29, 2006 | Issued |
Array
(
[id] => 4792941
[patent_doc_number] => 20080293915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-27
[patent_title] => 'Nanoscale Neuromodulating Platform For Retina Neuron Activation Apparatus and Method'
[patent_app_type] => utility
[patent_app_number] => 11/912754
[patent_app_country] => US
[patent_app_date] => 2006-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 28391
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0293/20080293915.pdf
[firstpage_image] =>[orig_patent_app_number] => 11912754
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/912754 | Nanoscale Neuromodulating Platform For Retina Neuron Activation Apparatus and Method | Apr 27, 2006 | Abandoned |
Array
(
[id] => 5342308
[patent_doc_number] => 20090180958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Diagnostic and therapeutic agents'
[patent_app_type] => utility
[patent_app_number] => 11/919426
[patent_app_country] => US
[patent_app_date] => 2006-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 21732
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20090180958.pdf
[firstpage_image] =>[orig_patent_app_number] => 11919426
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/919426 | Diagnostic and therapeutic agents | Apr 24, 2006 | Abandoned |
Array
(
[id] => 5759644
[patent_doc_number] => 20060210589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Methods for treating myofascial pain'
[patent_app_type] => utility
[patent_app_number] => 11/403666
[patent_app_country] => US
[patent_app_date] => 2006-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4298
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210589.pdf
[firstpage_image] =>[orig_patent_app_number] => 11403666
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/403666 | Methods for treating myofascial pain | Apr 12, 2006 | Issued |
Array
(
[id] => 4873632
[patent_doc_number] => 20080200366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-21
[patent_title] => 'Trimeric Peptides for Use in Treating Obesity'
[patent_app_type] => utility
[patent_app_number] => 11/911428
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14694
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0200/20080200366.pdf
[firstpage_image] =>[orig_patent_app_number] => 11911428
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/911428 | Trimeric Peptides for Use in Treating Obesity | Apr 6, 2006 | Abandoned |
Array
(
[id] => 4682804
[patent_doc_number] => 20080249030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'Age Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 11/909761
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15032
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20080249030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909761
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909761 | Age Inhibitors | Mar 29, 2006 | Abandoned |
Array
(
[id] => 5270904
[patent_doc_number] => 20090074680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-19
[patent_title] => 'STATHERIN PEPTIDE AND USE IN MEDICINE'
[patent_app_type] => utility
[patent_app_number] => 11/909342
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7436
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0074/20090074680.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909342
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909342 | STATHERIN PEPTIDE AND USE IN MEDICINE | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5596806
[patent_doc_number] => 20060160724
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Preserving a hemoglobin blood substitute with a transparent overwrap'
[patent_app_type] => utility
[patent_app_number] => 11/386956
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13552
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160724.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386956
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386956 | Preserving a hemoglobin blood substitute with a transparent overwrap | Mar 20, 2006 | Abandoned |
Array
(
[id] => 5350520
[patent_doc_number] => 20090005881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-01
[patent_title] => 'Composite Material Useful as Biomaterial and Its Preparation'
[patent_app_type] => utility
[patent_app_number] => 11/886318
[patent_app_country] => US
[patent_app_date] => 2006-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6352
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20090005881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886318
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886318 | Composite material useful as biomaterial and its preparation | Mar 13, 2006 | Issued |
Array
(
[id] => 795646
[patent_doc_number] => 07429562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-09-30
[patent_title] => 'Cyclosporin analog formulations'
[patent_app_type] => utility
[patent_app_number] => 11/375532
[patent_app_country] => US
[patent_app_date] => 2006-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10840
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/429/07429562.pdf
[firstpage_image] =>[orig_patent_app_number] => 11375532
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/375532 | Cyclosporin analog formulations | Mar 12, 2006 | Issued |
Array
(
[id] => 4663128
[patent_doc_number] => 20080254035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Lipocalin Protein'
[patent_app_type] => utility
[patent_app_number] => 11/817296
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 39187
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254035.pdf
[firstpage_image] =>[orig_patent_app_number] => 11817296
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/817296 | Lipocalin Protein | Mar 7, 2006 | Abandoned |
Array
(
[id] => 5786424
[patent_doc_number] => 20060205652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Formulations and methods for delivery of growth factor analogs'
[patent_app_type] => utility
[patent_app_number] => 11/361090
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17350
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205652.pdf
[firstpage_image] =>[orig_patent_app_number] => 11361090
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/361090 | Formulations and methods for delivery of growth factor analogs | Feb 22, 2006 | Issued |
Array
(
[id] => 5331266
[patent_doc_number] => 20090111743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-30
[patent_title] => 'Cysteine-branched heparin-binding growth factor analogs'
[patent_app_type] => utility
[patent_app_number] => 11/362137
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17486
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20090111743.pdf
[firstpage_image] =>[orig_patent_app_number] => 11362137
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/362137 | Cysteine-branched heparin-binding growth factor analogs | Feb 22, 2006 | Abandoned |
Array
(
[id] => 4822961
[patent_doc_number] => 20080227696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'Single branch heparin-binding growth factor analogs'
[patent_app_type] => utility
[patent_app_number] => 11/359173
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16792
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227696.pdf
[firstpage_image] =>[orig_patent_app_number] => 11359173
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/359173 | Single branch heparin-binding growth factor analogs | Feb 20, 2006 | Abandoned |
Array
(
[id] => 5563629
[patent_doc_number] => 20090136481
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-28
[patent_title] => 'Use of Myostatin (GDF-8) Antagonists for Treatment of Sarcopenia (Age-Related Muscle-Wasting)'
[patent_app_type] => utility
[patent_app_number] => 11/883854
[patent_app_country] => US
[patent_app_date] => 2006-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 13739
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20090136481.pdf
[firstpage_image] =>[orig_patent_app_number] => 11883854
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/883854 | Use of Myostatin (GDF-8) Antagonists for Treatment of Sarcopenia (Age-Related Muscle-Wasting) | Feb 6, 2006 | Abandoned |
Array
(
[id] => 103141
[patent_doc_number] => 07723499
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-25
[patent_title] => 'Specific binding agents of human angiopoietin-2'
[patent_app_type] => utility
[patent_app_number] => 11/343583
[patent_app_country] => US
[patent_app_date] => 2006-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 48577
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/723/07723499.pdf
[firstpage_image] =>[orig_patent_app_number] => 11343583
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/343583 | Specific binding agents of human angiopoietin-2 | Jan 29, 2006 | Issued |
Array
(
[id] => 5844932
[patent_doc_number] => 20060122378
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Novel method for purification of recombinant proteins'
[patent_app_type] => utility
[patent_app_number] => 11/336748
[patent_app_country] => US
[patent_app_date] => 2006-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5550
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20060122378.pdf
[firstpage_image] =>[orig_patent_app_number] => 11336748
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/336748 | Novel method for purification of recombinant proteins | Jan 18, 2006 | Abandoned |
Array
(
[id] => 5694095
[patent_doc_number] => 20060154242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Biomolecule chip and fabrication method thereof'
[patent_app_type] => utility
[patent_app_number] => 11/329240
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4343
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154242.pdf
[firstpage_image] =>[orig_patent_app_number] => 11329240
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/329240 | Biomolecule chip and fabrication method thereof | Jan 9, 2006 | Issued |
Array
(
[id] => 4786149
[patent_doc_number] => 20080139478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'IL-10 Related Peptides For Wound Healing'
[patent_app_type] => utility
[patent_app_number] => 11/795135
[patent_app_country] => US
[patent_app_date] => 2006-01-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16821
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0139/20080139478.pdf
[firstpage_image] =>[orig_patent_app_number] => 11795135
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/795135 | IL-10 Related Peptides For Wound Healing | Jan 5, 2006 | Abandoned |